The Prevalence of Fatty Liver Disease and Its Associated Factors Among Dayak Community in Kuching and Samarahan Division, Sarawak
Main Article Content
Abstract
Globally, fatty liver disease (FLD) shows a worrying pattern of substantial increase in prevalence from year 1990 to 2020. Despite this, there are limited studies on FLD in Malaysia where the FLD trend remained unascertained. In Sarawak, there is a particular concern on FLD in Dayak Community due to the increase in obesity trend among this community, which is known as one of the factors of FLD. Thus, this study aims to determine the prevalence of FLD and its associating factors among the Dayak community in Kuching and Samarahan divisions. Materials and methods: This study was a cross-sectional study with a cluster sampling conducted among 281 respondents. Data were collected through questionnaires, and ultrasound assessments was used to diagnose FLD, then data was analyzed with SPSS version 29.0. Results: The respondent's mean (SD) age was 52.5 (16.00) years old. Analysis revealed that 47.3% of the respondents had FLD. Most of the FLD were in the mild stage (69.9%), and none of the respondents were in the severe stage. Bivariate analysis revealed that the age group of 35 to 65 years (p<0.01), the overweight and obese group (p<0.001), the presence of comorbidities (p<0.05), and the presence of alcohol consumption (p<0.05) appeared to be significant predictors of FLD. Conclusion: The prevalence of FLD among the Dayak community in Kuching and Samarahan divisions was higher in comparison to previous studies which indicate an urgent needs of actions from the relevant departments.
Downloads
Article Details
References
Ayonrinde OT. Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD – Reconciling the present with the past. JHEP Reports. 2021;3(3).doi:10.1016/J.JHEPR.2021.100261.
Le MH, Yeo YH, Zou B, Barnet S, Henry L, Cheung R, et al. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach. Clinical and molecular hepatology. 2022;28(4).doi:10.3350/CMH.2022.0239.
Khammas ASA, Hassan HA, Salih SQM, Kadir H, Ibrahim RM, Nasir NNM, et al. Prevalence and risk factors of sonographically detected non alcoholic fatty liver disease in a screening centre in Klang Valley, Malaysia: an observational cross-sectional study. Porto Biomed J. 2019;4(2):e31.doi:10.1016/j.pbj.0000000000000031
Cheah WL, Lee PY, Chang CT, Mohamed H, Wong S. Prevalence of ultrasound diagnosed nonalcoholic fatty liver disease among rural indigenous community of Sarawak and its association with biochemical and anthropometric measures. The Southeast Asian journal of tropical medicine and public health. 2013;44:309-17.doi:PMCID 23691641.
Cheemerla S, Balakrishnan M. An Official Learning Resource of AASLD review Global epidemiology of Chronic liver Disease. 365 | CliniCal liver Disease. 2021;17(5).doi:10.1002/cld.1061.
Daniel W. Biostatistics: A Foundation for Analysis in the Health Sciences. New York: John Wiley & Sons,. 1999(7th edition. ).doi:ISBN 0-417-58852-0.
Chu AHY, Moy FM. Reliability and Validity of the Malay International Physical Activity Questionnaire (IPAQ-M)Among a Malay Population in Malaysia. Asia-Pacific Journal of Public Health. 2015;27:NP2381 - NP9.doi:10.1177/1010539512444120.
Yee A, Adlan ASA, Rashid RR, Habil H, Kamali K. Validation of the alcohol use disorders identification test (AUDIT) – Bahasa Malaysia version among a group of alcohol users. Journal of Substance Use. 2015;20(4):229-33.doi:10.3109/14659891.2014.894588.
Saunders JB, Aasland OG, Babor TF, De la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption II. Addiction 1993 [Available from: https://auditscreen.org/about/scoring-audit.
Department of Statistics Malaysia. Household income and basic amenities survey report by state and administrative district (Sarawak). Malaysia2019.
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.doi:10.1002/HEP.28431/SUPPINFO.
Lin Y, Feng X, Cao X, Miao R, Sun Y, Li R, et al. Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes. Diabetology & Metabolic Syndrome. 2022;14(1):181.doi:10.1186/s13098-022-00930-w.
Summart U, Thinkhamrop B, Chamadol N, Khuntikeo N, Songthamwat M, Kim CS. Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study. F1000Res. 2017;6:1630.doi:10.12688/f1000research.12417.2.
Chang CT, Lee PY, Cheah WL. The prevalence of cardiovascular risk factors in the young and middle-aged rural population in Sarawak, Malaysia. Malays J Med Sci. 2012;19(2):27-34.doi:PMC3431746.
Fan R, Wang J, Du J. Association between body mass index and fatty liver risk: A dose-response analysis. Sci Rep. 2018;8(1):15273.doi:10.1038/s41598-018-33419-6.
Abdul S, Suppiah S, Ibrahim RM, Mohamed Nasir NN, Bahari N, Hassan HA, et al. Prevalence of Ultrasound-diagnosed Non Alcoholic Fatty Liver Disease Among Rural Indigenous Population in Malaysian and Its Association With Biochemical and Anthropometric Measures. Malaysian Journal of Medicine & Health Sciences. 2021(3).doi:ISSN 1675-8544.
Im HJ, Ahn YC, Wang J-H, Lee MM, Son CG. Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea. Clinics and Research in Hepatology and Gastroenterology. 2021;45(4):101526.doi:doi.org/10.1016/j.clinre.2020.06.022.
Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2019;92:82-97.doi:doi.org/10.1016/j.metabol.2018.11.014.
Fu H, Yu H, Zhao Y, Chen J, Liu Z. Association between hypertension and the prevalence of liver steatosis and fibrosis. BMC Endocrine Disorders. 2023;23(1):85.doi:10.1186/s12902-023-01318-1.
Chen J, Hu P, Wang Y, Zhu Z. Association between type 2 diabetes status and prevalence of liver steatosis and fibrosis among adults aged ≥ 40 years. BMC Endocrine Disorders. 2022;22(1):128.doi:10.1186/s12902-022-01046-y.
Catanzaro R, Selvaggio F, Sciuto M, Zanoli L, Yazdani A, He F, et al. Triglycerides to high-density lipoprotein cholesterol ratio for diagnosing nonalcoholic fatty liver disease. Minerva Gastroenterol (Torino). 2022;68(3):261-8.doi:10.23736/s2724-5985.21.02818-x.
Nakagami H. Mechanisms underlying the bidirectional association between nonalcoholic fatty liver disease and hypertension. Hypertension Research. 2023;46(2):539-41.doi:10.1038/s41440-022-01117-6.
Tomah S, Alkhouri N, Hamdy O. Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? Clinical Diabetes and Endocrinology. 2020;6(1):9.doi:10.1186/s40842-020-00097-1.
Chen Y, Varghese Z, Ruan XZ. The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis. Genes & Diseases. 2014;1(1):106-12.doi:doi.org/10.1016/j.gendis.2014.07.007.
Robert Lourdes TG, Abd Hamid HA, Riyadzi MR, Rodzlan Hasani WS, Abdul Mutalip MH, Abdul Jabbar N, et al. Findings from a Nationwide Study on Alcohol Consumption Patterns in an Upper Middle-Income Country. Int J Environ Res Public Health. 2022;19(14).doi:10.3390/ijerph19148851.
Nik Mohd Shahril Nik Mohd Nor AKMI, Norliana Hashim, , Siti Anis Adilah Tarmazi, Siti Dorsiela Binti Dawi. A study of Sarawak ethnic food “Tuak” as means of communication in understanding culture. GADING (Online) Journal for Social Sciences. 2020;23(01).doi:ISSN 2600-7568.
Liu P, Xu Y, Tang Y, Du M, Yu X, Sun J, et al. Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men. PLOS ONE. 2017;12(7):e0181497.doi:10.1371/journal.pone.0181497.
You M, Crabb DW. Recent Advances in Alcoholic Liver Disease II. Minireview: molecular mechanisms of alcoholic fatty liver. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2004;287(1):G1-G6.doi:10.1152/ajpgi.00056.2004.
Kate H, Christian T, Sarah M, Thomas P, Quentin MA, Roy T, et al. Non-alcoholic fatty liver disease is associated with higher levels of <em>objectively</em> measured sedentary behaviour and lower levels of physical activity than matched healthy controls. Frontline Gastroenterology. 2015;6(1):44.doi:10.1136/flgastro-2014-100432.
Qiu S, Cai X, Sun Z, Li L, Zügel M, Steinacker JM, et al. Association between physical activity and risk of nonalcoholic fatty liver disease: a meta-analysis. Therap Adv Gastroenterol. 2017;10(9):701-13.doi:10.1177/1756283x17725977.